STAT

APRIL 25, 2024

In 2021 alone, the use of generic and biosimilar drugs saved $373 billion in health expenditures. More than 90% of prescriptions filled that year were for generics or biosimilars, up from just over 18% the year that Hatch-Waxman was passed. Today, however, generic drugs seem to be a victim of their success.

Prescription Filling 258

Prescription Filling Biosimilars Chemotherapy 258

Big Molecule Watch

SEPTEMBER 15, 2023

Generic & Biosimilar Medicines Savings Report highlighting the significant economic contributions of generic and biosimilar medicines. healthcare system, including patients, employers and taxpayers, saved $408 billion in 2022 by using FDA-approved generic and biosimilar drugs, per the AAM’s report. Notably, the U.S.

Biosimilars 69

Biosimilars Prescription Filling 69

FDA Law Blog: Biosimilars

DECEMBER 4, 2023

Within one month of each comprehensive review, the pharmacy must prepare a written report identifying prescriptions filled that were not issued for a legitimate medical purpose or filled outside the usual course of the professional practice of pharmacy, and prescriptions in violation of the permanent injunction terms.

Controlled Substances 139

Controlled Substances Documentation Dosage Prescription Filling 139

pharmaphorum

FEBRUARY 18, 2021

In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. Between December 1, 2018 and January 31, 2019, 65% of erectile dysfunction prescriptions filled were for Viagra or its generic version 12. Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively.

Prescription Filling 52

Prescription Filling Drug Pricing Biosimilars Compounding 52

Putting Patients First Blog

JANUARY 27, 2025

Formulary Inclusion and Placement of Generics and Biosimilars The NHC supports CMS proposals to improve formulary practices by prioritizing access to generics, biosimilars, and other cost-effective medications in the Medicare Part D program.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Safe Biologics

MARCH 10, 2025

Small molecule drugs make up over 90% of prescriptions filled in the U.S. A recent survey of doctors who prescribe biosimilars found that only 11% of physicians believe all biosimilars should be deemed interchangeable. Ben Ray Lujn, D-New Mexico, has supported efforts to loosen biosimilar standards.

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130